Pharmaceutical Executive-02-01-2005

For companies that are prepared, Part D represents a great opportunity. For others, failing to react quickly enough could be a costly mistake.

The LazarusEffect

The High Court ruled that Abbott should pay the agreed-on royalty of 5 percent rather than the 2 percent it's been paying. The difference may be worth $392 million

Physicians give only 25 percent of samples to newly diagnosed patients, along with a prescription.

One response to today's safety concerns is particularly alarming: The research community has become skittish about conducting clinical studies involving pain medications and other high-risk treatments.

As a reputation driver, ethical behavior has increased steadily in importance over the last three years.